Opinion: State drug importation programs will work with the FDA, not outside of it
State programs can use the global pharmaceutical supply chain to relieve the sometimes crushing financial burden of drug treatments — at least until we have an effective national approach to…
The safety of the supply chain for pharmaceuticals in the United States must be built with solid links. That hasn’t always been the case, which is why the (DQSA) was signed into law in 2013. Part of that law () mandates the development of a national “track-and-trace” electronic system that documents a drug’s distribution path from the manufacturing plant to the pharmacy counter. It facilitates detection and removal of potentially dangerous drugs from the drug supply chain. This system, which will be fully implemented in the next few years, will extend to drugs manufactured outside in the U.S. in FDA-registered facilities.
